Compare AU
Compare CNEW vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the China Growth Companies (CNEW) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
CNEW | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 52 | 240 |
Median incremental investment | $702.18 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,913.73 | $1,703.28 |
Average age group | > 35 | 26 - 35 |
Key Summary
CNEW | IXJ | |
|---|---|---|
Strategy | CNEW.AX was created on 2018-11-08 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. CNEW.AX gives investors a portfolio of the most fundamentally sound companies in China having the best growth prospects in sectors making up the New Economy, namely technology, health care, consumer staples and consumer discretionary. CNEW.AX aims to provide investment returns, before fees and other costs, which track the performance of the Index. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | Changbai Mountain Tourism Co Ltd Class A (1.57 %) Zhejiang China Commodities City Group Co Ltd Class A (1.20 %) Toread Holdings Group Co Ltd Class A (1.15 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Consumer Discretionary (42.76 %) Other (36.77 %) Industrials (19.40 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | China (100.00 %) | United States (99.97 %) |
Management fee | 0.95 % | 0.46 % |
Key Summary
CNEW | IXJ | |
|---|---|---|
Issuer | VanEck | iShares |
Tracking index | CSI MarketGrader China New Economy Index - CNY | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.95 % | 0.46 % |
Price | $7.07 | $141.31 |
Size | $122.169 million | $1.380 billion |
10Y return | N/A | 129.40 % |
Annual distribution yield (5Y) | 1.53 % | 1.26 % |
Market | ASX | ASX |
First listed date | 09/11/2018 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
CNEW | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 52 | 240 |
Median incremental investment | $702.18 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,913.73 | $1,703.28 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
CNEW | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
CNEW | IXJ |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |